Upload
fyoon
View
216
Download
0
Embed Size (px)
Citation preview
8/7/2019 CB and Risk Analysis
1/21
Risk Analysis and CapitalBudgeting
Copyright 2010 by the McGraw-Hill Companies, Inc. All rights reserved. McGraw-Hill/Irwin
8/7/2019 CB and Risk Analysis
2/21
7-1
Sequential DecisionAn approach to reduce risk in capital
budgeting
Decisions are made stage by stageEg: develop a prototype, test the market, thenconsider bigger investment
Overcome large losses
8/7/2019 CB and Risk Analysis
3/21
7-2
7.4 Decision TreesAllow us to graphically represent thealternatives available to us in each period and
the likely consequences of our actionsThis graphical representation helps to identifythe best course of action .
Helpful to evaluate sequential decision andreal options
8/7/2019 CB and Risk Analysis
4/21
7-3
Example of a Decision Tree
Do notstudy
Studyfinance
Squares represent decisions to be made . Circles representreceipt of information,e.g ., a test score .
The lines leading awayfrom the squaresrepresent the alternatives .
C
A
B
F
D
8/7/2019 CB and Risk Analysis
5/21
7-4
7.1 S ensitivity and Scenario AnalysisAllow us to look behind the NPVnumber to see how stable our estimatesare .Enable us to assess the risk of the project
Improve our estimate of expected NPV
8/7/2019 CB and Risk Analysis
6/21
8/7/2019 CB and Risk Analysis
7/21
7-6
Decision Tree for Stewart
Do nottest
Test
Failure
Success
Do notinvest
Invest
Invest
The firm has two decisions to make:
To test or not to test .
To invest or not to invest .
0$! NPV
NPV = $3.4 b
NPV = $0
NPV = $91.4 6 m
8/7/2019 CB and Risk Analysis
8/21
7-7
NPV Following Successful Test Note that the NPV iscalculated as of date 1, thedate at which the
investment of $ 1,600million is made . Later we bring this number back todate 0 . Assume a cost of capital of 10% .
Investment Year 1 Years 2-5Revenues $ 7,000
Variable Costs ( 3,000)Fixed Costs ( 1,800)Depreciation ( 400)
Pretax profit $ 1,800Tax ( 34 %) (6 12 )
Net Profit $ 1,188
Cash Flow -$1,600 $ 1,588
75.433,3$)10.1(
588,1$600,1$
1
4
1
1
!
! !
NPV
NPV t
t
8/7/2019 CB and Risk Analysis
9/21
7-8
NPV Following Unsuccessful Test Note that the NPV iscalculated as of date 1,the date at which theinvestment of $ 1,600million is made . Later we bring this number
back to date 0 . Assume acost of capital of 10% .
Investment Year 1 Years 2-5Revenues $ 4,050
Variable Costs ( 1,735 )Fixed Costs ( 1,800)Depreciation ( 400)
Pretax profit $ 115Tax ( 34 %) (39.10)
Net Profit $ 75. 90Cash Flow -$1,600 $ 475. 90
461.91$)10.1(90.475$
600,1$
1
4
1
1
NPV
NPV t
t
8/7/2019 CB and Risk Analysis
10/21
7-9
Decision to TestLets move back to the first stage, where the decision boilsdown to the simple question: should we invest?The expected payoff evaluated at date 1 is:
v
v!
failuregivenPayoff
failureProb.
successgivenPayoff
sucessProb.
payoff Expected
25.060,2$0$40.75.433,3$60. payoff
Expected !vv!
95.872$10.1
25.060,2$000,1$ !! NPV
The NPV evaluated at date 0 is:
So, we should test .
8/7/2019 CB and Risk Analysis
11/21
7-1 0
Sensitivity Analysiswhat-if -analysisExamine how sensitive a particular NPV calculation tochanges in underlying factors (such as market share, variablecosts, discount rate)Underlying factors for revenue- market share- market size- priceUnderlying factor for cost- variable costs- fixed cost
8/7/2019 CB and Risk Analysis
12/21
7-11
Sensitivity Analysis: Stewart
2.1,7
,7,6R ev !!(
W e can see that NPV is very sensitive to changes in revenues . In the Stewart Pharmaceuticals example, a 14 % drop inrevenue leads to a 6 1% drop in NPV .
%3.675.433,3
75.433,364.341,1% !! NPV
For every 1% drop in revenue, we can expect roughly a4.2 6% drop in NPV:
%29.14%9.6
26.4 !
8/7/2019 CB and Risk Analysis
13/21
7-12
Scenario Analysis: StewartA variation on sensitivity analysis is scenario analysis .For example, the following three scenarios could apply
to Stewart Pharmaceuticals:1. The next few years each have heavy cold seasons, and
sales exceed expectations, but labor costs skyrocket .2. The next few years are normal, and sales meet
expectations .3. The next few years each have lighter than normal cold
seasons, so sales fail to meet expectations .
Other scenarios could apply to FDA approval .
For each scenario, calculate the NPV .
8/7/2019 CB and Risk Analysis
14/21
7-13
7.2 Monte Carlo SimulationMonte Carlo simulation is a further attempt to model real -world uncertainty .This approach takes its name from thefamous European casino, because itanalyzes projects the way one mightevaluate gambling strategies .
8/7/2019 CB and Risk Analysis
15/21
7-14
Monte Carlo SimulationMonte Carlo simulation of capital budgeting projectsis often viewed as a step beyond either sensitivity
analysis or scenario analysis .Interactions between the variables are explicitlyspecified in Monte Carlo simulation; so, at leasttheoretically, this methodology provides a more
complete analysis .W hile the pharmaceutical industry has pioneeredapplications of this methodology, its use in other industries is far from widespread .
8/7/2019 CB and Risk Analysis
16/21
7-15
Monte Carlo SimulationStep 1: S pecify the Basic ModelStep 2: S pecify a Distribution for EachVariable in the ModelStep 3: The Computer Draws One OutcomeStep 4: Repeat the ProcedureStep 5: Calculate NPV
8/7/2019 CB and Risk Analysis
17/21
7-1 6
Break -Even AnalysisCommon tool for analyzing the relationship
between sales volume and profitability
There are two common break -even measuresAccounting break -even: sales volume at whichnet income = 0
Financial break -even: sales volume at which net present value = 0
8/7/2019 CB and Risk Analysis
18/21
7-17
Accounting Break -Even AnalysisCosts are classified into fixed cost ( FC)(which include depreciation) and variable cost
per unit (VC)Operating profit = 0[Q*(P VC) FC] (1- T) = 0
Q*(P - VC) = FCTotal contribution margin = total fixed cost
8/7/2019 CB and Risk Analysis
19/21
7-1 8
Financial Break -even NPV = OAnnual Net Cash flow = 0Total contribution margin after tax = totalfixed cash outflowQ(P -VC)( 1-T) = FC (1- T) T (D) + EACW here EAC = equivalent annual cost of theinvestmentEAC = IO/PVI FAr,n
8/7/2019 CB and Risk Analysis
20/21
7-1 9
Financial Break -even NPV = 0ACF * PVI FAr,n = IO[Q(P - VC)( 1-T) FC (T) + D (T)] PVI FAr,n = IOQ(P -VC)( 1-T) = FC (1- T) T (D) + EAC
8/7/2019 CB and Risk Analysis
21/21
7-2 0
Break -Even Analysis: ExampleSigma has purchased a new machine for RM2,000,000 to produce a new type of mixer . The
machine has an economic life of five years over which it will be depreciated based on the straightline method . The sale price per unit of mixer isRM400, the variable cost is RM60 and the fix cost is
RM750,000 . Assume a tax rate of 28% and adiscount rate of 10%, calculate the present value breakeven point .
Answer: 3904 unit